350: A multicenter, randomized, double-blind, placebo-controlled phase 2 trial of retosiban, a selective oxytocin receptor antagonist, for the management of preterm labor

Jerry Snidow; Hugh Miller; Guillermo Valenzuela; Steve Thornton; Brendt Stier; Linda Clayton; Mike Fossler; Tim Montague; Kathleen Beach; Pauline Williams

doi:10.1016/j.ajog.2012.10.515

350: A multicenter, randomized, double-blind, placebo-controlled phase 2 trial of retosiban, a selective oxytocin receptor antagonist, for the management of preterm labor

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2012.10.515 ◽

2013 ◽

Vol 208 (1) ◽

pp. S155 ◽

Cited By ~ 6

Author(s):

Jerry Snidow ◽

Hugh Miller ◽

Guillermo Valenzuela ◽

Steve Thornton ◽

Brendt Stier ◽

...

Keyword(s):

Receptor Antagonist ◽

Preterm Labor ◽

Oxytocin Receptor ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Trial

Download Full-text

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue

American Journal of Obstetrics and Gynecology ◽

10.1067/mob.2000.95834 ◽

2000 ◽

Vol 182 (5) ◽

pp. 1173-1183 ◽

Cited By ~ 214

Author(s):

Roberto Romero ◽

Baha M. Sibai ◽

Luis Sanchez-Ramos ◽

Guillermo J. Valenzuela ◽

Jean-Claude Veille ◽

...

Keyword(s):

Receptor Antagonist ◽

Preterm Labor ◽

Controlled Trial ◽

Oxytocin Receptor ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A double-blind placebo-controlled trial of an oxytocin-receptor antagonist (antocin) in the treatment of preterm labor

American Journal of Obstetrics and Gynecology ◽

10.1016/s0002-9378(97)80072-5 ◽

1997 ◽

Vol 176 (1) ◽

pp. S2 ◽

Cited By ~ 8

Author(s):

B.M. Sibai ◽

R. Romero ◽

L. Sanchez-Ramos ◽

G. Valenzuela ◽

J.C. Veille ◽

...

Keyword(s):

Receptor Antagonist ◽

Preterm Labor ◽

Controlled Trial ◽

Oxytocin Receptor ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A double-blind placebo-controlled trial of oxytocin receptor antagonist (Antocin) maintenance therapy in patients with preterm labor

American Journal of Obstetrics and Gynecology ◽

10.1016/s0002-9378(97)80139-1 ◽

1997 ◽

Vol 176 (1) ◽

pp. S30 ◽

Cited By ~ 8

Author(s):

L. Sanchez-Ramos ◽

G. Valenzuela ◽

R. Romero ◽

H. Silver ◽

W. Koltun ◽

...

Keyword(s):

Maintenance Therapy ◽

Receptor Antagonist ◽

Preterm Labor ◽

Controlled Trial ◽

Oxytocin Receptor ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF AN OXYTOCIN-RECEPTOR ANTAGONIST(ANTOCIN) IN THE TREATMENT OF PRETERM LABOR. • 1054

Pediatric Research ◽

10.1203/00006450-199704001-01073 ◽

1997 ◽

Vol 41 ◽

pp. 178-178

Author(s):

Baha M. Sibai

Keyword(s):

Receptor Antagonist ◽

Preterm Labor ◽

Controlled Trial ◽

Oxytocin Receptor ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis

Journal of Cystic Fibrosis ◽

10.1016/j.jcf.2013.12.009 ◽

2014 ◽

Vol 13 (2) ◽

pp. 148-155 ◽

Cited By ~ 73

Author(s):

M.W. Konstan ◽

G. Döring ◽

S.L. Heltshe ◽

L.C. Lands ◽

K.A. Hilliard ◽

...

Keyword(s):

Cystic Fibrosis ◽

Lung Disease ◽

Receptor Antagonist ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Trial ◽

Ltb4 Receptor

Download Full-text

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis

CHEST Journal ◽

10.1016/j.chest.2018.08.1058 ◽

2018 ◽

Vol 154 (5) ◽

pp. 1061-1069 ◽

Cited By ~ 33

Author(s):

Scott M. Palmer ◽

Laurie Snyder ◽

Jamie L. Todd ◽

Benjamin Soule ◽

Rose Christian ◽

...

Keyword(s):

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Receptor Antagonist ◽

Lysophosphatidic Acid ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Receptor ◽

Lysophosphatidic Acid Receptor ◽

Phase 2 Trial

Download Full-text

A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF OXYTOCIN RECEPTOR ANTAGONIST(ANTOCIN) MAINTENANCE THERAPY IN PATIENTS WITH PRETERM LABOR. † 1031

Pediatric Research ◽

10.1203/00006450-199704001-01050 ◽

1997 ◽

Vol 41 ◽

pp. 174-174

Author(s):

Luis Sanchez-Ramos

Keyword(s):

Maintenance Therapy ◽

Receptor Antagonist ◽

Preterm Labor ◽

Controlled Trial ◽

Oxytocin Receptor ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Safety and efficacy of idalopirdine, a 5-HT 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial

The Lancet Neurology ◽

10.1016/s1474-4422(14)70198-x ◽

2014 ◽

Vol 13 (11) ◽

pp. 1092-1099 ◽

Cited By ~ 100

Author(s):

David Wilkinson ◽

Kristian Windfeld ◽

Eskild Colding-Jørgensen

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Receptor Antagonist ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Phase 2 Trial

Download Full-text

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Yearbook of Paediatric Endocrinology ◽

10.1530/ey.17.14.9 ◽

2020 ◽

Author(s):

Harrison SA ◽

Bashir MR ◽

Guy CD ◽

Zhou R ◽

Moylan CA ◽

...

Keyword(s):

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Alcoholic Steatohepatitis ◽

Phase 2 Trial

Download Full-text

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Yearbook of Paediatric Endocrinology ◽

10.1530/ey.15.15.7 ◽

2018 ◽

Author(s):

Harrison SA ◽

Rinella ME ◽

Abdelmalek MF ◽

Trotter JF ◽

Paredes AH ◽

...

Keyword(s):

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Alcoholic Steatohepatitis ◽

Phase 2 Trial

Download Full-text